Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Jaguar Health (JAGX) Net Margin (2016 - 2025)

Jaguar Health (JAGX) has disclosed Net Margin for 11 consecutive years, with 716.94% as the latest value for Q4 2025.

  • Quarterly Net Margin fell 42529.0% to 716.94% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 469.09% through Dec 2025, down 13567.0% year-over-year, with the annual reading at 465.42% for FY2025, 13612.0% down from the prior year.
  • Net Margin for Q4 2025 was 716.94% at Jaguar Health, down from 312.94% in the prior quarter.
  • The five-year high for Net Margin was 65.59% in Q4 2022, with the low at 89930.0% in Q1 2022.
  • Average Net Margin over 5 years is 7366.34%, with a median of 431.06% recorded in 2022.
  • The sharpest move saw Net Margin crashed -5353909bps in 2022, then skyrocketed 8929679bps in 2023.
  • Over 5 years, Net Margin stood at 670.4% in 2021, then skyrocketed by 90bps to 65.59% in 2022, then plummeted by -508bps to 398.7% in 2023, then grew by 27bps to 291.65% in 2024, then plummeted by -146bps to 716.94% in 2025.
  • According to Business Quant data, Net Margin over the past three periods came in at 716.94%, 312.94%, and 354.48% for Q4 2025, Q3 2025, and Q2 2025 respectively.